Traditionally, the study of medicine has focused on individual diseases. In reality, however, diseases tend to co-occur in individual patients, a concept known as multimorbidity. Multimorbidity most often is seen in geriatric practice. Empirical data on patients with multiple chronic disorders and clinical care guidelines based on single conditions are insufficient to inform medical care of patients with >1 medical condition.
Methods
This article reviews concepts of multimorbidity in the published literature in the context of substance use disorders, other psychiatric disorders, and associated social and environmental problems in other populations, including public sector service populations.
Results
Besides historically recognized co-occurrence of 3 dimensions of illness, including multiple medical illnesses, psychiatric disorders, and substance use disorders in varying combinations with one another, a fourth dimension of multimorbidity that includes associated social and environmental conditions fits within this construction.
Conclusions
Additional steps are needed to address more effectively the needs of patients with substance use and other psychiatric disorders in the public sector psychiatric systems of care. These efforts will need to address the systems theory approach to multimorbidity that entails the socioeco-nomic and environmental aspects of their conditions.
Get full access to this article
View all access options for this article.
References
1.
DoosL, RobertsEO, CorpN, . Multi-drug therapy in chronic condition multimorbidity: a systematic review. Fam Pract. 2014;31:654–663.
2.
UhligK, LeffB, KentD, . A framework for crafting clinical practice guidelines that are relevant to the care and management of people with multimorbidity. J Gen Intern Med. 2014;29:670–679.
3.
SinnigeJ, BraspenningJ, SchellevisF, . The prevalence of disease clusters in older adults with multiple chronic diseases—a systematic literature review. PLo S One.2013;8:e79641. doi: 10.1371/journal.pone.0079641.
4.
WeissCO, VaradhanR, PuhanMA, . Multimorbidity and evidence generation. J Gen Intern Med. 2014;29:653–660.
5.
HoffmanC, RiceD, SungHY.Persons with chronic conditions. Their prevalence and costs. JAMA. 1996;276:1473–1479.
6.
FraccaroP, ArguelloCM, AinsworthJ, . Adoption of clinical decision support in multimorbidity: a systematic review. JMIR Med Inform. 2015;3:e4. doi: 10.2196/medinform.3503.
7.
FortinM, LapointeL, HudonC, . Multimorbidity is common to family practice: is it commonly researched? Can Fam Physician. 2005;51:244–245.
8.
WolffJL, StarfieldB, AndersonG.Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162:2269–2276.
9.
ManginD, HeathI, JamoulleM.Beyond diagnosis: rising to the multimorbidity challenge. BMJ. 2012;344:e3526. doi: 10.1136/bmj.e3526.
10.
Lefèvre T, d'IvernoisJF, DeA, . What do we mean by multimorbidity? An analysis of the literature on multimorbidity measures, associated factors, and impact on health services organization. Rev Epidemiol Sante Publique. 2014;62:305–314.
11.
HuntleyAL, JohnsonR, PurdyS, . Measures of multimorbidity and morbidity burden for use in primary care and community settings: a systematic review and guide. Ann Fam Med. 2012;10:134–141.
12.
ViolanC, Foguet-BoreuQ, Flores-MateoG, . Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLo S One.2014;9:e102149. doi: 10.1371/journal.pone.0102149.
13.
MarengoniA, AnglemanS, MelisR, . Aging with multimorbidity: a systematic review of the literature. Aging Res Rev. 2011;10:430–439.
14.
ValderasJM, StarfieldB, SibbaldB, . Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7:357–363.
15.
HaibachJP, BeehlerGP, DollarKM, . Moving toward integrated behavioral intervention for treating multimorbidity among chronic pain, depression, and substance-use disorders in primary care. Med Care. 2014;52:322–327.
FortinM, StewartM, PoitrasME, . A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Ann Fam Med. 2012;10:142–151.
18.
FriedTR, O'LearyJ, TowleV, . The effects of comorbidity on the benefits and harms of treatment for chronic disease: a systematic review. PLo S One.2014;9:e112593. doi: 10.1371/journal.pone.0112593.
19.
FabbriE, ZoliM, Gonzalez-FreireM, . Aging and multimorbidity: new tasks, priorities, and frontiers for integrated gerontological and clinical research. J Am Med Dir Assoc. 2015;16:640–647.
20.
BoydCM, DarerJ, BoultC, . Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294:716–724.
21.
Jakovljević M, Ostojić L. Comorbidity and multimorbidity in medicine today: challenges and opportunities for bringing separated branches of medicine closer to each other. Psychiatr Danub. 2013;25:(suppl 1)18–28.
22.
BoydCM, LucasGM. Patient-centered care for people living with multimorbidity. Curr OpinHIV AIDS.2014;9:419–427.
23.
FeinsteinAR.The pre-therapeutic classification of comorbidity in chronic disease. J Chronic Dis. 1970;23:455–468.
24.
WittigJR.Elder people in institutions - problems concerning health and hygiene [in German]. Zentralbl Bakteriol Orig B.1976;163:238–253.
25.
SchwarzfischerVP.Serum glycoside level in old age. Problems of course control in glycoside therapy [in German]. Fortschr Med. 1976;94:841–846.
26.
van den AkkerM, BuntixF, KnottnerusA.Comorbidity or multimorbidity: what's in a name? A review of literature. Eur J Gen Pract. 1996;2:65–70.
27.
DiederichsC, BergerK, BartelsDB.The measurement of multiple chronic diseases—a systematic review on existing multimorbidity indices. J Gerontol A Biol Sci Med Sci.2011;66:301–311.
28.
SartorettiC, Sartoretti-ScheferS, RuckertR, . Comorbid conditions in old patients with femur fractures. J Trauma. 1997;43:570–577.
29.
Medrano GonzálezF, MeleroBM, Barba RomeroMA, . Comorbidity, pluripathology, resource use and prognosis of patients hospitalized in internal medicine areas [in Spanish]. An Med Interna. 2007;24:525–530.
30.
BeydonN, Tubiana-RufiN.The Ceduc, a multi-pathology therapeutic education centre [in French]. Soins Pediatr Pueric. 2011;28–29.
31.
ZwebenJE, SmithDE.Considerations in using psychotropic medication with dual diagnosis patients in recovery. J Psychoactive Drugs. 1989;21:221–228.
32.
MuthC, van den AkkerM, BlomJW, . The Ariadne principles: how to handle multimorbidity in primary care consultations. BMC Med. 2014;12:223.
33.
LuznyJ, BellovaJ, DonekE.Does gerontopsychiatry belong to medicine? Cross-sectional study monitoring polymorbidity in hospitalized gerontopsychiatric patients. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010;154:89–92.
34.
KesslerRC, ChiuW T, DemlerO, . Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617–627.
35.
KesslerRC, McGonagleKA, ZhaoS, . Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8–19.
36.
MooneyGH.Addictions and social compassion. Drug Alcohol Rev. 2005;24:137–141.
37.
DohrenwendBP.Socioeconomic status (SES) and psychiatric disorders. Are the issues still compelling? Soc Psychiatry Psychiatr Epidemiol. 1990;25:41–47.
38.
NorthCS, EyrichKM, PollioDE, . Are rates of psychiatric disorders in the homeless population changing? Am J Publ Health. 2004;94:103–108.
39.
HeshkaS, AllisonDB.Is obesity a disease? Int J Obes Relat Metab Disord. 2001;25:1401–1404.
40.
Von BertalanffyL.The theory of open systems in physics and biology. Science. 1950;111:23–29.
41.
Von BertalanffyL.The history and status of general systems theory. Acad Manage J.1972;15:407–426.
42.
BronfenbrennerU.The ecology of human development: experiments by nature and design. Cambridge, MA: Harvard University Press; 1979.
43.
BronfenbrennerU, CesiSJ.Nature-nurture reconceptualized in developmental perspective: a bioecological model. Psychol Rev. 1994;101:568–586.
44.
NorthCS, PollioDE, SmithEM, . Correlates of early onset and chronicity of homelessness in a large urban homeless population. J Nerv Ment Dis. 1998;186:393–400.
45.
StahlerGJ, MennisJ, CotlarR, . The influence of neighborhood environment on treatment continuity and rehospitalization in dually diagnosed patients discharged from acute inpatient care. Am J Psychiatry. 2009;166:1258–1268.
46.
StahlerGJ, MennisJ, BaronDA.Geospatial technology and the “exposome”: new perspectives on addiction. Am J Public Health. 2013;103:1354–1356.
47.
LiddyC, BlazkhoV, MillK.Challenges of self-management when living with multiple chronic conditions: systematic review of the qualitative literature. Can Fam Physician. 2014;60:1123–1133.
48.
Jakovljević M, ReinerZ, MilicićD, . Comorbidity, multimorbidity and personalized psychosomatic medicine: epigenetics rolling on the horizon. Psychiatr Danub. 2010;22:184–189.
49.
MajM.Physical health care in persons with severe mental illness: a public health and ethical priority. World Psychiatry. 2009;8:1–2.
50.
AjetunmobiO, TaylorM, StocktonD, . Early death in those previously hospitalised for mental healthcare in Scotland: a nationwide cohort study, 1986-2010. BMJ Open. 2013;3. pii: e002768. doi: 10.1136/bmjopen-2013-002768.
51.
EatonWW, RothKB, BruceM, . The relationship of mental and behavioral disorders to all-cause mortality in a 27-year follow-up of 4 epidemiologic catchment area samples. Am J Epidemiol. 2013;178:1366–1377.
52.
PetrakisIL, NichC, RalevskiE.Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram. Schizophr Bull. 2006;32:644–654.
53.
RalevskiE, Olivera-FigueroaLA, PetrakisI.PTSD and comorbid AUD: a review of pharmacological and alternative treatment options. Subst Abuse Rehabil. 2014;5:25–36.
54.
PettinatiHM, O'BrienCP, DundonWD.Current status of co-occurring mood and substance use disorders: a new therapeutic target. Am J Psychiatry. 2013;170:23–30.
55.
TietQQ, MausbachB.Treatments for patients with dual diagnosis: a review. Alcohol Clin Exp Res. 2007;31:513–536.
56.
GallantMP.The influence of social support on chronic illness self-management: a review and directions for research. Health Educ Behav. 2003;30:170–195.
57.
PriestJ, BuikemaA, Engel-NitzNM, . Quality of care, health care costs, and utilization among Medicare Part D enrollees with and without low-income subsidy. Popul Health Manag. 2012;15:101–112.
58.
BoeingH, BechtholdA, BubA, . Critical review: vegetables and fruit in the prevention of chronic diseases. Eur J Nutr. 2012;51:637–663.
